CALCIUM STEARATE

Hazard statements (CLP)

H319, H335

Code

Statements

H319

Causes serious eye irritation

SECTION 2: Hazards identification

Regulation, UK SI 2019/720, and UK SI 2020/1567 Classification of the substance or mixture Classified according to GB-CLP Regulation, UK SI 2019/720 and UK SI 2020/1567 [1] Legend H319 - Serious Eye Damage/Eye Irritation Category 2, H335 - Specific Target Organ Toxicity - Single Exposure (Respiratory Tract Irritation) Category 3 Classified by Chemwatch; 2. Classification drawn from GB-CLP Regulation, UK SI 2019/720 and UK SI 2020/1567

Signal word

Warning

Hazard statements

H319 Causes serious eye irritation. H335 May cause respiratory irritation.

Supplemental label elements

Not Applicable

Prevention

P271 Use only outdoors or in a well-ventilated area. P261 Avoid breathing dust/fume/gas/mist/vapours/spray. P280 Wear protective gloves/protective clothing/eye protection/face protection. P264 Wash all exposed external body areas thoroughly after handling.

Response

P305+P351+P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P312 Call a POISON CENTER/doctor/physician/first aider/if you feel unwell. P337+P313 If eye irritation persists: Get medical advice/attention. P304+P340 IF INHALED: Remove person to fresh air and keep comfortable for breathing.

Storage

P405 Store locked up. P403+P233 Store in a well-ventilated place. Keep container tightly closed.

Disposal

P501 Dispose of contents/container to authorised hazardous or special waste collection point in accordance with any local regulation. Material contains calcium stearate.

Other hazards

Ingestion may produce health damage*. Cumulative effects may result following exposure*. May produce skin discomfort*. Repeated exposure potentially causes skin dryness and cracking*. *LIMITED EVIDENCE REACH - Art.57-59 The mixture does not contain Substances of Very High Concern (SVHC) at the SDS print date. This substance/mixture does not meet the criteria for classification as Persistent, Bioaccumulative, and Toxic (PBT) in accordance with Annex XIII, Commission Delegated Regulation (EU) 2017/2100, and Commission Regulation (EU) 2018/605. This substance/mixture does not meet the criteria for classification as very Persistent and very Bioaccumulative (vPvB) in accordance with Annex XIII, Commission Delegated Regulation (EU) 2017/2100, and Commission Regulation (EU) 2018/605. This substance/mixture does not meet the criteria for classification as Persistent, Mobile and Toxic (PMT) in accordance with Commission Delegated Regulation (EU) 2023/707. This substance/mixture does not meet the criteria for classification as very Persistent and very Mobile (vPvM) in accordance with Commission Delegated Regulation (EU) 2023/707. The substance/mixture does not contain components considered to have endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605, nor is it included in the list established under REACH Article 59(1), at concentrations equal to or greater than 0.1% (w/w). No further product hazard information.

2.1 Classification of the substance or mixture

Classified according to GB-CLP Regulation, UK SI H319 - Serious Eye Damage/Eye Irritation Category 2, H335 - Specific Target Organ Toxicity - Single Exposure (Respiratory 2019/720 and UK SI Tract Irritation) Category 3 2020/1567 [1] Legend: 1. Classified by Chemwatch; 2. Classification drawn from GB-CLP Regulation, UK SI 2019/720 and UK SI 2020/1567